Journal of Korean Neurosurgical Society

The Korean Neurosurgical Society (대한신경외과학회)
권호 표지
DOI QR코드

DOI QR Code

Intravenous Magnesium Infusion for the Prevention of Symptomatic Cerebral Vasospasm after Aneurysmal Subarachnoid Hemorrhage

  • Jeon, Jin-Sue (Department of Neurosurgery, Hallym University College of Medicine, Chuncheon Sacred Heart Hospital) ;
  • Sheen, Seung-Hun (Department of Neurosurgery, Hallym University College of Medicine, Chuncheon Sacred Heart Hospital) ;
  • Hwang, Gyo-Jun (Department of Neurosurgery, Hallym University College of Medicine, Chuncheon Sacred Heart Hospital) ;
  • Kang, Suk-Hyung (Department of Neurosurgery, Hallym University College of Medicine, Chuncheon Sacred Heart Hospital) ;
  • Heo, Dong-Hwa (Department of Neurosurgery, Hallym University College of Medicine, Chuncheon Sacred Heart Hospital) ;
  • Cho, Yong-Jun (Department of Neurosurgery, Hallym University College of Medicine, Chuncheon Sacred Heart Hospital)
  • Received : 2012.01.09
  • Accepted : 2012.08.14
  • Published : 2012.08.28
Download PDF
⟨ Previous Next ⟩

Abstract

Objective : The study examined the difference in the incidence of symptomatic cerebral vasospasm with magnesium supplementation in aneurysmal subarachnoid hemorrhage (SAH) in a Korean population. Methods : This retrospective analysis was performed in 157 patients diagnosed with aneurysmal SAH from January 2007 to December 2011 at a single center. Seventy patients (44.6%) received a combination treatment of nimodipine with magnesium and 87 patients (55.4%) received only nimodipine. A matched case-control study using propensity scores was conducted and 41 subjects were selected from each group. A dosage of 64 mmol/day of magnesium was administrated. Results : The infusion of magnesium did not reduce the incidence of symptomatic cerebral vasospasm (n=7, 17.1%, p=0.29) compared with simple nimodipine injection (n=11, 26.8%). The ratios of good clinical outcome (modified Rankin scale 0-2) at 6 months were similar, being 78% in the combination treatment group and 80.5% in the nimodipine only group (p=0.79). The proportions of delayed cerebral infarction was not significantly lower in patients with combination treatment (n=2, 4.9% vs. n=3, 7.3%; p=0.64). There was no difference in the serum magnesium concentrations between the patients with symptomatic vasospasm and without vasospasm who had magnesium supplementation. No major complications associated with intravenous magnesium infusion were observed. Conclusion : Magnesium supplementation (64 mmol/day) may not be beneficial for the reduction of the incidence of symptomatic cerebral vasospasm in patients with aneurysmal SAH.

Keywords

References

  1. Altura BT, Altura BM : Interactions of Mg and K on cerebral vessels--aspects in view of stroke. Review of present status and new findings. Magnesium 3 : 195-211, 1984
  2. Barbarawi M, Smith SF, Jamous MA, Haboub H, Suhair Q, Abdullah S : Therapeutic approaches to cerebral vasospasm complicating ruptured aneurysm. Neurol Int 1 : e13, 2009 https://doi.org/10.4081/ni.2009.e13
  3. Biondi A, Ricciardi GK, Puybasset L, Abdennour L, Longo M, Chiras J, et al. : Intra-arterial nimodipine for the treatment of symptomatic cerebral vasospasm after aneurysmal subarachnoid hemorrhage : preliminary results. AJNR Am J Neuroradiol 25 : 1067-1076, 2004
  4. Boet R, Mee E : Magnesium sulfate in the management of patients with Fisher Grade 3 subarachnoid hemorrhage : a pilot study. Neurosurgery 47 : 602-606; discussion 606-607, 2000
  5. Collignon FP, Friedman JA, Piepgras DG, Pichelmann MA, McIver JI, Toussaint LG 3rd, et al. : Serum magnesium levels as related to symptomatic vasospasm and outcome following aneurysmal subarachnoid hemorrhage. Neurocrit Care 1 : 441-448, 2004 https://doi.org/10.1385/NCC:1:4:441
  6. Friedlich D, Agner C, Boulos AS, Mesfin F, Feustel P, Bernardini GL, et al. : Retrospective analysis of parenteral magnesium sulfate administration in decreased incidence of clinical and neuroradiological cerebral vasospasm : a single center experience. Neurol Res 31 : 621-625, 2009 https://doi.org/10.1179/174313209X38232
  7. Keyrouz SG, Diringer MN : Clinical review : prevention and therapy of vasospasm in subarachnoid hemorrhage. Crit Care 11 : 220, 2007 https://doi.org/10.1186/cc5958
  8. Macdonald RL, Curry DJ, Aihara Y, Zhang ZD, Jahromi BS, Yassari R : Magnesium and experimental vasospasm. J Neurosurg 100 : 106-110, 2004 https://doi.org/10.3171/jns.2004.100.1.0106
  9. Mori K, Yamamoto T, Miyazaki M, Hara Y, Aiko Y, Koike N, et al. : Optimal cerebrospinal fluid magnesium ion concentration for vasodilatory effect and duration after intracisternal injection of magnesium sulfate solution in a canine subarachnoid hemorrhage model. J Neurosurg 114 :1168-1175, 2011 https://doi.org/10.3171/2010.10.JNS10866
  10. Mori K, Yamamoto T, Nakao Y, Osada H, Hara Y, Oyama K, et al. : Initial clinical experience of vasodilatory effect of intra-cisternal infusion of magnesium sulfate for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Neurol Med Chir (Tokyo) 49 : 139-144; discussion 144-145, 2009 https://doi.org/10.2176/nmc.49.139
  11. Muir KW, Lees KR, Ford I, Davis S : Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial) : randomised controlled trial. Lancet 363 : 439-445, 2004 https://doi.org/10.1016/S0140-6736(04)15490-1
  12. Polin RS, Coenen VA, Hansen CA, Shin P, Baskaya MK, Nanda A, et al. : Efficacy of transluminal angioplasty for the management of symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 92 : 284-290, 2000 https://doi.org/10.3171/jns.2000.92.2.0284
  13. Rubin DB, Thomas N : Combining propensity score matching with additional adjustments for prognostic covariates. J Am Stat Assoc 95 : 573-585, 2000 https://doi.org/10.1080/01621459.2000.10474233
  14. Sang N, Meng Z : Blockade by magnesium of sodium currents in acutely isolated hippocampal CA1 neurons of rat. Brain Res 952 : 218-221, 2002 https://doi.org/10.1016/S0006-8993(02)03217-1
  15. Satoh A, Sugiyama T, Ooigawa H, Nakajima H, Ogura T, Neki H, et al. : Prevention of symptomatic vasospasm by continuous cisternal irrigation with mock-CSF containing ascorbic acid and Mg(2+). Acta Neurochir Suppl 107 : 115-118, 2010
  16. van den Bergh WM, Albrecht KW, Berkelbach van der Sprenkel JW, Rinkel GJ : Magnesium therapy after aneurysmal subarachnoid haemorrhage a dose-finding study for long term treatment. Acta Neurochir (Wien) 145 : 195-199; discussion 199, 2003 https://doi.org/10.1007/s00701-002-1064-9
  17. van den Bergh WM, Algra A, van der Sprenkel JW, Tulleken CA, Rinkel GJ : Hypomagnesemia after aneurysmal subarachnoid hemorrhage.Neurosurgery 52 : 276-281; discussion 281-282, 2003 https://doi.org/10.1227/01.NEU.0000043984.42487.0E
  18. van den Bergh WM, Algra A, van Kooten F, Dirven CM, van Gijn J, Vermeulen M, et al. : Magnesium sulfate in aneurysmal subarachnoid hemorrhage : a randomized controlled trial. Stroke 36 : 1011-1015, 2005 https://doi.org/10.1161/01.STR.0000160801.96998.57
  19. van den Bergh WM, Dijkhuizen RM, Rinkel GJ : Potentials of magnesium treatment in subarachnoid haemorrhage. Magnes Res 17 : 301-313, 2004
  20. Veyna RS, Seyfried D, Burke DG, Zimmerman C, Mlynarek M, Nichols V, et al. : Magnesium sulfate therapy after aneurysmal subarachnoid hemorrhage. J Neurosurg 96 : 510-514, 2002 https://doi.org/10.3171/jns.2002.96.3.0510
  21. Westermaier T, Stetter C, Vince GH, Pham M, Tejon JP, Eriskat J, et al. : Prophylactic intravenous magnesium sulfate for treatment of aneurysmal subarachnoid hemorrhage : a randomized, placebo-controlled, clinical study. Crit Care Med 38 : 1284-1290, 2010 https://doi.org/10.1097/CCM.0b013e3181d9da1e
  22. Wong GK, Poon WS, Chan MT, Boet R, Gin T, Ng SC, et al. : Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage (IMASH) : a randomized, double-blinded, placebo-controlled, multicenter phase III trial. Stroke 41 : 921-926, 2010 https://doi.org/10.1161/STROKEAHA.109.571125
  23. Wong GK, Poon WS, Chan MT, Boet R, Gin T, Ng SC, et al. : Plasma magnesium concentrations and clinical outcomes in aneurysmal subarachnoid hemorrhage patients : post hoc analysis of intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage trial. Stroke 41 : 1841-1844, 2010 https://doi.org/10.1161/STROKEAHA.110.585232
  24. Yahia AM, Kirmani JF, Qureshi AI, Guterman LR, Hopkins LN : The safety and feasibility of continuous intravenous magnesium sulfate for prevention of cerebral vasospasm in aneurysmal subarachnoid hemorrhage. Neurocrit Care 3 : 16-23, 2005 https://doi.org/10.1385/NCC:3:1:016

Cited by

  1. Inflammation, Cerebral Vasospasm, and Evolving Theories of Delayed Cerebral Ischemia vol.2013, pp.None, 2012, https://doi.org/10.1155/2013/506584
  2. The Harmful Effects of Subarachnoid Hemorrhage on Extracerebral Organs vol.2014, pp.None, 2012, https://doi.org/10.1155/2014/858496
  3. Effect of stenting on progressive occlusion of small unruptured saccular intracranial aneurysms with residual sac immediately after coil embolization: a propensity score analysis vol.8, pp.10, 2016, https://doi.org/10.1136/neurintsurg-2015-011947
  4. Genome-Wide Association between the 2q33.1 Locus and Intracranial Aneurysm Susceptibility: An Updated Meta-Analysis Including 18,019 Individuals vol.8, pp.5, 2019, https://doi.org/10.3390/jcm8050692
  5. Characterization of the TCR β Chain CDR3 Repertoire in Subarachnoid Hemorrhage Patients with Delayed Cerebral Ischemia vol.21, pp.9, 2012, https://doi.org/10.3390/ijms21093149
  6. Monitoring of Delayed Cerebral Ischemia in Patients with Subarachnoid Hemorrhage via Near-Infrared Spectroscopy vol.9, pp.5, 2012, https://doi.org/10.3390/jcm9051595
  7. The Role of Consecutive Plasma Copeptin Levels in the Screening of Delayed Cerebral Ischemia in Poor-Grade Subarachnoid Hemorrhage vol.11, pp.4, 2012, https://doi.org/10.3390/life11040274
  8. Application of Near-Infrared Spectroscopy for the Detection of Delayed Cerebral Ischemia in Poor-Grade Subarachnoid Hemorrhage vol.35, pp.2, 2021, https://doi.org/10.1007/s12028-021-01318-w
  9. Application of Near-Infrared Spectroscopy for the Detection of Delayed Cerebral Ischemia in Poor-Grade Subarachnoid Hemorrhage vol.35, pp.3, 2021, https://doi.org/10.1007/s12028-021-01223-2